Goosby says PEPFAR remains among 'highest priorities' of Obama administration, welcomes partnership with South African president Zuma

Eric Goosby, head of PEPFAR, on Wednesday reemphasized the U.S. commitment to fighting HIV/AIDS globally, the Associated Press reports. Despite concerns by international aid groups that the current economic climate might force HIV/AIDS funding to be scaled back, "Goosby said President Barack Obama and Secretary of State Hillary Rodham Clinton have assured him his program remains among 'the highest priorities,'" the news service writes.

Goosby's comments came during a telephone interview from Washington, where he "also described a new era of cooperation with South Africa, the nation that bears the greatest AIDS burden" and is also "the largest recipient of PEPFAR funds," according to the AP. "We are very gratified to be able to partner with the Zuma administration in a much more robust manner," Goosby said.

According to Mary Fanning, head of health programs at the U.S. Embassy in Pretoria, South Africa, PEPFAR's budget for the country was set to get a $10 million increase for 2010-2011 from the previous year. Fanning said the U.S. seeks to help the country meet its goals in the fight against HIV/AIDS and "in an unprecedented move … left 5 percent of next year's budget free to be used as the South African government saw fit," the AP writes (Bryson, 11/18).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug